Stocks · Health care · Biological Products, (No Diagnostic Substances)

aTYR PHARMA INC

ATYR Clue Score30
United States Fiscal year ends December CIK 0001339970 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Paul Schimmel
27 May 2026
Director
Buy indirect
100,000
$0.50
$49.63K
Nancy Denyes
4 Feb 2026
General Counsel
Sell
1,118
$0.98
$1.09K
Jill Marie Broadfoot
4 Feb 2026
Chief Financial Officer
Sell
1,558
$0.98
$1.52K
Sanjay Shukla
4 Feb 2026
President and CEO
Sell
3,745
$0.98
$3.66K

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 16,812
History held since 8 May 2015